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SUMMARY 
1,3-Propanediol (1,3-PD) is one of the most important chemicals widely used as mono-
mers for synthesis of some commercially valuable products, including cosmetics, foods, 
lubricants and medicines. Although 1,3-PD can be synthesized both chemically and bio-
synthetically, the latter offers more merits over chemical approach as it is economical-
ly viable, environmentally friendly and easy to carry out. The biosynthesis of 1,3-PD can 
be done by transforming glycerol or other similar substrates using some bacteria, such 
as Clostridium butyricum and Klebsiella pneumoniae. However, these natural microorgan-
isms pose some bottlenecks like low productivity and metabolite inhibition. To overcome 
these problems, recent research efforts have been focused more on the development of 
new strains by modifying the genome through different techniques, such as mutagene-
sis and genetic engineering. Genetically engineered strains obtained by various strategies 
cannot only gain higher yield than wild types, but also overcome some of the barriers in 
production by the latter. This review paper presents an overview on the recent advances 
in the technological approaches to develop genetically engineered microorganisms for 
efficient biosynthesis of 1,3-PD.
Key words: glycerol, 1,3-propanediol, biosynthesis, genetically engineered strain, mu-
tagenesis
INTRODUCTION
In recent years, sustainable development and resource recycling have become in-
creasingly vital. With the popularity of biological production of commercially important 
metabolites, the biosynthesis of various products such as cosmetics, food, fuels, lubri-
cants, plastics, beverages, fibres and medicines are put into practice (1). Biological ap-
proaches possess the huge potential to reduce the production of harmful bioproducts. 
The renewable resource biodiesel, which is derived from vegetable or animal fat transes-
terification, is a biodegradable and non-toxic fuel, representing an alternative source of 
energy. Crude glycerol is a major byproduct of biodiesel production. In consideration of 
the increasing global demand for biodiesel, there will be increasing crude glycerol pro-
duced (2,3). The crude glycerol waste, if unable to be disposed or recycled in time, will not 
only raise the cost of biodiesel production, but also become a new source of pollution. 
For example, the emission of crude glycerol waste into aquatic habitat may destroy the 
aquatic ecological environment and endanger the survival of hydrobiose, weakening the 
fishing industry (4). Solutions have been offered to alleviate these environmental issues, 
for instance, the crude glycerol is required to be purified before discarding. However, the 
requirement for sophisticated equipment as well as increased costs of the purification 
process make it difficult to purify glycerol wastes (5). Therefore, the transformation to 
other specific chemicals by microorganisms has become a significant method for recy-
cling this byproduct. 1,3-Propanediol (1,3-PD) is one of the most well-known biotechno-
logical conversion products of glycerol by some specific bacteria, such as Lactobacillus 
brevis, Citrobacter freundii, Klebsiella pneumoniae, Enterobacter agglomerans, Clostridium 
pasteurianum, Clostridium butyricum and Clostridium beijerinckii (6–8). 
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1,3-PD is colourless, tastes slightly sweet, and a vis-
cous liquid easily miscible with water and ethanol (9,10). 
It can be implemented as a monomer for the production 
of plastics with particular properties. For example, 1,3-PD 
can be the monomer of a new kind of polyester, namely 
polypropylene terephthalate (PTT), which can be efficient-
ly used as a polyglycol-type lubricant. This property pro-
vides this polyester with extremely unique characteristics 
(11). Besides, 1,3-PD has been applied widely in many other 
industrial fields, such as the production of composites, ad-
hesives, laminates, coatings, mouldings, aliphatic polyes-
ters, and antifreeze (12,13). 1,3-PD can be produced through 
two kinds of chemical pathways: the hydroformylation of 
ethylene oxide and the hydration of acrolein (11,14). Howev-
er, many drawbacks like high consumption of energy, usage 
of expensive catalysts, and release of toxic intermediates in-
crease its manufacturing cost by chemical methods. There-
fore, biological methods of producing 1,3-PD with many 
advantages are used as an alternative way for making this 
process easier (15–17). 
In biological production, the choice of appropriate 
co-substrates with glycerol for fermentation is of great im-
portance, which can affect the yield of 1,3-PD. In previous 
studies, researchers have explored many co-substrates 
from different sources for glycerol bioconversion (18). For 
instance, Apiwatanapiwat et al. (19) cultivated a strain of C. 
butyricum on glycerol medium supplemented with cassava 
pulp. The results showed that the cassava pulp increased 
the productivity of 1,3-PD by almost 50 % compared with 
the medium with glycerol as sole carbon source. Neverthe-
less, there are some other drawbacks of 1,3-PD conversion, 
such as the growth inhibition of bacterial cells, which in-
creases with the increase in concentrations of glycerol or 
1,3-PD (20,21). Moreover, the toxic intermediate 3-hydroxy-
propionaldehyde (3-HPA), accumulated during fermenta-
tion along with other metabolites such as acetate, lactate, 
2,3-butanediol and ethanol, also affects the cell growth 
(22,23). Besides, expensive coenzyme B
12
 may be needed 
in this process (24) (Fig. 1). Hence, the selection of an effi-
cient microorganism to debottleneck this problem is an-
other important factor. 
Even though the wild type strains mentioned above 
showed a good ability to produce 1,3-PD, genetically engi-
neered strains have shown a greater potential to improve 
their performance. As advanced evolution technology, ge-
netic engineering methods like knockout and overexpres-
sion of relevant genes are used to create high-efficiency or 
high-productivity engineering strains (25). Moreover, con-
ventional mutagenesis methods by some physical or chem-
ical mutagens (single or complex) also provide a good way 
to alter the titres, yields or productivities. Therefore, in this 
study, genetic engineering methods and conventional mu-
tagenesis methods for the production of 1,3-PD are chiefly 
reviewed. Also, recent development and prospects of these 
methods are briefly elaborated. 
METABOLIC MECHANISMS OF 1,3-PD SYNTHESIS
Biological pathway for the synthesis of 1,3-propanediol
In nature, 1,3-propanediol (1,3-PD) can only be produced 
from glycerol, i.e. glycerol dissimilation pathway is the sole 
pathway of 1,3-PD generation (26). Some microorganisms are 
able to use glycerol as the sole carbon source under anaerobic 
conditions. In these microbes, glycerol can penetrate the mem-
brane in two different ways, by simple diffusion or by facilitated 
diffusion. The transmembrane protein of facilitated diffusion is 
a kind of glycerol transport facilitator called GlpF (TC 1.A.8.1.1) 
(27,28). This facilitator selectively allows compounds (small neu-
tral linear molecules) to pass through the cell membrane. When 
glycerol enters into the cell, it will be metabolized via two par-
allel fluxes: oxidative and reductive pathways. 
In the oxidative branch, glycerol is oxidized to dihy-
droxyacetone (DHA, coded by dhaD), which is catalyzed by 
NAD+-dependent glycerol dehydrogenase (GDH). After this, 
DHA is phosphorylated by adenosine triphosphate (ATP)-de-
pendent dihydroxyacetone kinase (DHAK, coded by dhaK) into 
dihydroxyacetone phosphate (DHAP), which enters into carbon 
flux towards glycolysis, TCA and other major metabolic path-
ways (24). Then, the converted pyruvate is metabolized further 
to produce the major cellular constituents, such as acetate, suc-






The second, reductive branch leads to 1,3-PD formation 
(Fig. 2). In this branch, glycerol is initially reduced to 3-HPA 
catalyzed by glycerol dehydratase (GDHt, coded by dhaB). The 
catalytic activity of this enzyme requires coenzyme B
12
 to be an 
essential cofactor in most bacteria (in C. butyricum it is B
12
-inde-
pendent) (29). Afterwards, catalyzed by NADH-dependent 1,3- 
-PD oxidoreductase (PDOR, coded by dhaT), 3-HPA is reduced 
to 1,3-PD. In the process of anaerobic conversion from glycerol 
to 1,3-PD, when all the acetyl-CoA enters the TCA cycle, with no 
Fig. 1. Metabolic pathway of glycerol conversion (24)
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acetate formed, a maximum theoretical yield of 0.875 mol/mol 
is reached. However, in most cases, ATP is generated by forma-
tion of acetate, so the maximum theoretical yield with acetate 
as the sole byproduct is 0.72 mol/mol (6).
concentration of 1,3-PD of 60 g/L. When exogenous 1,3-PD 
was added at an initial concentration of 80 g/L, it was lethal 
to the bacteria. Colin et al. (33) also studied the inhibitory 
effect of 1,3-PD in C. butyricum CNCM 1211. In their study, 
the tolerance levels were similar, and they discussed that the 
particular inhibitory effect of 1,3-PD was not related to os-
motic pressure but rather to a modification of membrane 
organization by an increase in the fluidity of the membrane, 
causing the ethanol inhibition in microbial fermentation. 
Finally, byproduct formation and maintaining redox bal-
ance is another bottleneck of 1,3-PD production. As shown 
in Fig. 1, in the metabolic pathway of glycerol, many kinds of 
other metabolites apart from 1,3-PD are generated simulta-
neously, becoming the byproducts of 1,3-PD production. In 
the oxidative branch, glycerol is transformed to phosphoen-
olpyruvate (PEP) through several steps catalyzed by some 
ATP-dependent oxidoreductases. For the mainstream meta-
bolic pathway glycolysis, glucose is also transformed to PEP. 
Then PEP is catalyzed by pyruvate kinase to pyruvate, which 
fluxes to byproduct formation. Many factors can affect this 
process, such as external and genetic conditions. As a con-
sequence, both quality and quantity of the byproducts are 
affected (28). Carbon from glycerol or glucose is consumed 
during the formation of these byproducts, resulting in a 
decrease in the titre of target product. Some of these by-
products are also toxic to the cells, inhibiting their growth. 
Therefore, the deletion of genes which cause the formation 
of these byproducts should be a good solution. However, 
these multiple pathways can adjust the balance of intracel-
lular redox, i.e. the redox potential should be kept to stabilize 
the proteins when deleting these relative genes. The forma-
tion of unnecessary metabolites should be avoided and the 
balance of redox should be maintained. This is a challenge 
for the improvement of the product (34).
So far, researchers have attempted to debottleneck var-
ious steps of bioprocesses, and some progress has been 
made, but further attention should be paid to achieve more 
desired effects.
GENETIC ENGINEERING METHODS
Recently, genetic engineering has become increasing-
ly popular. Inactivating or overexpressing the genes of the 
pathway of interest or the pathway favourably influencing 
the performance may overcome the barriers in 1,3-PD bio-
production. There are many advantages in genetic engineer-
ing, i.e. biochemical reactions can be modified specifically 
and the target strains can be designed to suit a particular 
purpose by the recombinant DNA technology. As a result 
of this modification of related genes, the product forma-
tion or cellular properties can be improved directly. Besides, 
the high throughput screening can be avoided. Construct-
ing 1,3-PD engineering strains is a promising technology. A 
comparison between wild strains and various genetic en-
gineering mutants in 1,3-PD production in recent years is 
shown in Table 1 (20,23,35-42). 
Fig. 2. Glycerol reductive pathway in various microbes: Kp=Klebsiel-
la pneumoniae, Cb=Clostridium butyricum, Cf=Citrobacter freundii, 
Cp=Clo stridium pasteurianum, Lb=Lactobacillus brevis (6)
The bottlenecks of glycerol bioconversion
In the field of 1,3-PD bioproduction, there are many bot-
tlenecks. Firstly, in the reductive branch of glycerol dissimila-
tion, the synthesized intermediary compound 3-HPA is tox-
ic to the bacteria and can prevent their growth. It has been 
widely applied as biological sterilization agent and anti-in-
fection treatment agent. The exact mechanism is not very 
clear now (30). Besides, the two key enzymes of the branch, 
GDHt and PDOR are both susceptible to high concentrations 
of 3-HPA, which lowers their activity. As a result, the produc-
tion of toxic 3-HPA in the culture media is triggered by a pos-
itive feedback mechanism, i.e. the increase of 3-HPA will re-
press the activity of GDHt in order to decrease the harmful 
effect of the toxicant. Hence, the decreased intermediates 
cause a low titre of the target product. This process triggers 
irreversible cessation of metabolic activity, which becomes 
a serious limitation to the 1,3-PD production process (31). 
Secondly, the accumulation of 1,3-PD itself also inhib-
its cellular growth. Szymanowska-Powałowska and Kubiak 
(32) tested the effect of 1,3-PD in C. butyricum DSP1. 1,3-PD 
was added to the medium at the beginning of the cultiva-
tion prior to inoculation. The results showed that relatively 
high activity of the analyzed strain was maintained up to a 
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Inactivation of genes 
The inactivation of genes associated with byproduct for-
mation is an effective strategy exploited in metabolic en-
gineering of 1,3-PD production (28,32). In oxidative branch 
of glycerol conversion mentioned above, many byprod-
ucts are formed. Among them, organic acids and ethanol 
are more toxic to bacteria than glycerol and 1,3-PD. A sig-
nificant amount of the byproducts influences the ability of 
microbes to produce 1,3-PD. In addition, they cause high 
amount of energy consumption in downstream purification 
processes. Therefore, the elimination of byproduct formation 
is a good choice in 1,3-PD production. Gene knockout re-
fers to a kind of genetic engineering modification by which 
one of the genes is made inoperative (30). The salient feature 
of this technology is that the biological function of a gene 
whose sequence is known but function unknown can be es-
timated by blocking the gene. It is also widely used by many 
researchers to inactivate the genes related to byproducts to 
improve the production (32). Careful consideration about 
which gene to be inactivated should be required.
Inactivation of genes associated with DHA or DHAP 
The dhaD gene encodes the NAD+-linked glycerol dehy-
drogenase (GDH). GDH catalyzes the oxidation from glyc-
erol to DHA. Furthermore, enzyme DHAK encoded by dhaK 
gene catalyzes the phosphorylation from DHA to DHAP. This 
is the first step of oxidation branch (24). During the biolog-
ical production of 1,3-PD, the formation of byproducts in-
creases the purification cost and time. In particular, similar 
boiling points of 2,3-BD and 1,3-PD make purification much 
more difficult. One solution is to inactivate the two genes 
associated with DHA and DHAP. Horng et al. (23) inactivated 
the dhaD and dhaK by genetic engineering strategy to pre-
vent the byproduct accumulation during 1,3-PD production 
in K. pneumoniae. The mutant strain TC100 deficient in GDH 
activity was generated by insertion-deletion of a streptomy-
cin resistance marker into the dhaD-dhaK genes. The byprod-
ucts such as lactate, 2,3-BD and ethanol were not detected 
when this mutant was used for fermentation. The bacterial 
cells were cultured in 50-mL flasks and incubated at 37 °C. 
The yield of 1,3-PD by TC100 was increased by about 2.06 
times compared to the wild type strain after 48 h of incuba-
tion. However, this mutant produced less biomass and had 
smaller productivity of 1,3-PD than the parent strain, so the 
production was optimized by gene overexpression (men-
tioned below) and incubation conditions were adjusted to 
solve this problem.
Total elimination of byproduct formation in the oxidative 
branch decreases the biomass. In return, the decreased bio-
mass affects the reductive branch of glycerol dissimilation 
pathway, resulting in the decrease of 1,3-PD yield. The rea-
son is that in the glycerol dissimilation pathway, the forma-
tion of byproducts in the oxidative branch provides reduc-
tive power for 1,3-PD synthesis (34). The problem that total 
elimination causes low 1,3-PD yield can also be solved by dis-
connecting the production and growth pathways. Maervoet 
et al. (35) studied the 1,3-PD production of Citrobacter werk-
manii. Genetic tools were used to create C. werkmanii DSM 
17579 ∆dhaD, in which dhaD gene was deleted. The mutant 
strain used glucose and glycerol to increase the biomass. As 
a result, the 1,3-PD yield on glycerol was improved 1.5 times.
Inactivation of genes associated with pyruvate reduction
Lactate is one of the byproducts of the reduction of pyru-
vate, which requires one molecule of NADH. It is a major by-
product in glycerol fermentation shunting the carbon flow 
away from pyruvate and leading to the decrease of 1,3-PD 
yield (26). During cell growth, lactate is accumulated in the 
late exponential phase, which prevents cellular growth. There-
fore, many researchers have obtained lactate-deficient mu-
tants so far to prevent the synthesis of lactate, which is of 
great significance for 1,3-PD fermentation (36-38). The con-
crete practice is knocking out the ldhA gene encoding lactate 
dehydrogenase. In addition, 2,3-BD is another main byprod-
uct of the reduction of pyruvate in glycerol-based fermenta-
tion. As 2,3-BD is also a diol like 1,3-PD, they have similar boil-
ing points and 1,3-PD is very hydrophilic (37). Therefore, this 
causes a serious obstacle to efficiently separate highly pure 
Table 1. Comparison of 1,3-propanediol production using various mutants by genetic engineering









C. werkmanii DSM 17579 adhE, dhaD and ldhA 8.12 0.82 1.59 (20)
K. pneumoniae TC100 dhaD and dhaK 3.77 0.31 2.06 (23)
C. werkmanii DSM 17579 dhaD - 0.74 1.50 (35)
K. pneumoniae 2-1 ldhA and ald 87.5 0.70 1.10 (36)
K. pneumoniae KG5 poxB, pta and ackA 76.8 0.54 1.15 (37)
K. pneumoniae J2B ldhA 58.0 0.35 2.63 (38)
Overexpression K. pneumoniae ME-308 yqhD from E. coli 67.6 0.51 1.25 (39)
K. pneumoniae KG1 dhaT 55.8 0.50 1.60 (40)
K. pneumoniae DSM 2026 puuC 16.8 0.42 2.16 (41)
K. pneumoniae AK dhaT 25.9 - 1.88 (42)
Y=yield
Food Technol. Biotechnol. 56 (1) 3-15 (2018)
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1,3-PD from 2,3-BD. Naturally, the deletion of genes associ-
ated with 2,3-BD is a good idea to change this phenomenon 
and decrease the cost of purification. 
Durgapal et al. (38) examined the ability of K. pneumoniae 
J2B to produce 1,3-PD from glycerol. In their study, a lactate 
dehydrogenase-deficient mutant was constructed. The wild 
type and ∆ldhA mutant strain were grown and compared 
under different culture conditions and different cultivation 
mode (batch or fed-batch). When K. pneumoniae ∆ldhA was 
cultivated in glycerol fed-batch mode, a promising result 
was obtained: the titre of 1,3-PD was 58.0 g/L with a yield of 
0.35 g/g and an overall volumetric productivity of 1.3 g/(L·h). 
The analysis of carbon balance suggested that the ∆ldhA mu-
tant strain produced negligible lactate but more 2,3-BD than 
wild strain. 2,3-BD became the main byproduct (the titre was 
26.6 g/L) and less than 10 g/L of the other metabolites was 
detected. Therefore, in the following study (43) they delet-
ed the 2,3-BD pathway genes, budA, budB, budC and budO 
(whole-bud operon) of K. pneumoniae J2B ∆ldhA. The result 
showed that the strain ∆budO eliminated 2,3-BD production 
completely but generated less 1,3-PD. It was shown that the 
accumulation of a significant amount of pyruvate is proba-
bly responsible for the decrease of 1,3-PD production. Some 
other research groups (40-42) also paid attention to the de-
letion of both ldhA gene and genes associated with 2,3-BD, 
such as als gene encoding acetolactate synthase in the bio-
synthesis of 2,3-BD. Oh et al. (44) focused on the mutants 
of K. pneumoniae with deletions of the als and ldhA genes. 
However, when using the mutants for producing 1,3-PD in 
the fed-batch fermentation, only the ∆ldhA strain was able 
to produce the maximum 1,3-PD (102.7 g/L).
Inactivation of genes associated with acetyl-CoA reduction
Not only does the carbon flow from pyruvate to lactate, 
but it also flows to acetyl-CoA. As a result, many byproducts 
are produced. In the metabolic process of pyruvate, cata-
lyzed by aldehyde dehydrogenase, acetyl-CoA is a signifi-
cant mid-product. Afterwards, acetyl-CoA is reduced to oth-
er metabolites like acetate, ethanol and butyrate (22). Many 
kinds of mutants which are deficient in these byproducts 
have been developed (20,36). 
Acetate is an inhibitory metabolite to cellular growth. 
Among these metabolites from acetyl-CoA, acetate is the 
most toxic (26). Therefore, elimination of acetate synthesis 
is the most significant target in metabolic engineering of 1,3- 
-PD production. Lin et al. (37) studied the effects of deletion 
of the genes poxB encoding pyruvate oxidase, pta encoding 
phosphotransacetylase and ackA encoding acetate kinase on 
cell growth and 1,3-PD yield of K. pneumoniae. These genes 
are all involved in the two main acetate synthesis pathways. 
The final 1,3-PD titre in the fed-batch fermentation reached 
76.8 g/L, which was 15 % higher than that of wild strain. 
These deletions severely decreased the formation of ace-
tate and more carbon flowed to TCA cycle, and as a result 
the production of 1,3-PD was enhanced.
Ethanol is another key competitor to the formation of 
1,3-PD (39). The formation of ethanol begins with the trans-
formation from acetyl-CoA to acetaldehyde catalyzed by 
aldehyde dehydrogenase (encoded by aldH). Then, with 
catalyzed ethanol dehydrogenase (encoded by adhE), acet-
aldehyde is reduced to ethanol. This process needs four mol-
ecules of NADH. NADH acts as co-enzyme in the formation 
of ethanol, decreasing the quantity of NADH in reductive 
branch (28). The elimination of lactate combined with etha-
nol synthesis is also a promising method. In order to improve 
1,3-PD production by K. pneumoniae, Chen et al. (36) delet-
ed the relative genes and obtained K. pneumoniae 2-1∆ldhA, 
K. pneumoniae 2-1∆aldH and K. pneumoniae 2-1∆ldhA∆aldH 
mutant strains. In a fed-batch culture, the production of 1,3- 
-PD from glycerol was enhanced and the concentrations of 
byproducts were reduced compared with the original strain 
K. pneumoniae 2-1. The maximum titres of 1,3-PD were 85.7, 
82.5 and 87.5 g/L compared with 78.8 g/L of the parental 
strain. Maervoet et al. (20) deleted the gene adhE singly, dou-
bled with dhaD, and tripled with dhaD and ldhA in C. werkma-
nii. The single knockout showed that the yield of 1,3-PD was 
0.7 mol/mol glycerol, while the yield obtained by the use of 
wild strain was 0.63 mol/mol. The result of double knockout 
was 0.96 mol/mol and of triple knockout was 1.0 mol/mol. 
The most promising result was that the maximum theoretical 
yield of 1.00 mol/mol glycerol and a final titre of (107.20±4.2) 
mmol/L 1,3-PD was reached when grown in shake flasks with 
glucose and glycerol as carbon sources under anaerobic con-
ditions (20). 
Overexpression of genes
In addition to the inactivation of genes, many research-
ers have tried to optimize production via the overexpression 
of reductive pathway (45). As the name implies, the overex-
pression of genes is an abnormally and excessively high level 
of gene expression which produces a pronounced gene-re-
lated phenotype (46). The salient feature of overexpression 
is that the process can be carried out not only in the original 
cells where it exists (homologous host), but also in another 
expressing system (heterologous host). The target genes to 
be overexpressed can be obtained from both the same pro-
ducers and other existing cells (47). 
Overexpression of genes associated with the original 
pathway
In the reductive branch of glycerol dissimilation, the two 
key enzymes, GDHt and PDOR, are encoded by dhaB and 
dhaT, respectively. As a result, the activity of the two en-
zymes can be enhanced and 1,3-PD yield can be increased 
as well. In addition, the enzyme PDOR is NADH-dependent 
(24). When the byproduct pathways were deleted, the intra-
cellular redox balance (NADH/NAD+) was extremely high in 
these mutants, which has already been confirmed by some 
researchers. Therefore, these groups investigated further 
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how to overexpress genes dhaB and dhaT to use these saved 
NADH (46,48). 
In the study of Cui et al. (40), the dhaT gene was overex-
pressed in two mutants of K. pneumoniae, KG1-3T (blocking 
of the 2,3-butanediol pathway only) and KG1-5T (blocking of 
both 2,3-BD and lactate pathways). The results showed that 
in KG1-5T, the redox balance was restored to normal and 1,3- 
-PD yield was enhanced. The yield of 1,3-PD from glycerol 
in KG1-5T was restored to the normal level of 0.6. Oh et al. 
(42) first obtained a mutant of K. pneumoniae without the by-
product formation by deleting the oxidative branch of glyc-
erol. Then, they studied the overexpression of the dhaB and/
or dhaT genes in this mutant to improve the 1,3-PD yield. The 
results suggested that the mutant overexpressing dhaT alone 
gained the highest yield of the three mutants. In fed-batch fer-
mentation, efficient production of 1,3-PD from either pure or 
crude glycerol was gained and no byproducts were formed. 
Overexpression of genes apart from the original pathway
Many researchers are seeking other methods that do not 
focus on the original 1,3-PD pathway. One of them is to clone 
the genes encoding the enzymes involved in the 1,3-PD syn-
thesis pathway found in other natural strains of bacteria (49). 
Heterologous recombinant strains can also be constructed 
by metabolic engineering. These genes are expressed and 
isozymes are obtained for 1,3-PD fermentation. For exam-
ple, yqhD gene from E. coli can encode an oxidoreductase 
which was found to possess the same function as PDOR from 
K. pneumoniae, and was thus considered as 1,3-PD oxidore-
ductase isoenzyme (PDORI) (32). Many researchers investigat-
ed this gene and cloned it into 1,3-PD producers to increase 
the yield. Zhu et al. (39) used a K. pneumoniae mutant with 
overexpression of PDORI, which surprisingly led to higher 1,3- 
-PD production. The final 1,3-PD concentration of recombi-
nant K. pneumoniae reached 67.6 g/L, which was 125.33 % of 
that by the parent strain and the yield reached 0.62 mol/mol. 
The conversion activity of the enzyme in the recombinant 
mutant was detected. The maximum was increased 10-fold 
compared with the wild strain under the same conditions. 
Besides, the concentration of the toxic intermediate 3-HPA 
was reduced by 22.4 % when compared to the original strain. 
Therefore, the overexpression of genes can also solve the in-
hibitory problem posed on the cell growth by the interme-
diary metabolite 3-HPA in the reductive branch of glycerol 
dissimilation.
Another method to decrease the concentration of 3-HPA 
during 1,3-PD fermentation is to convert 3-HPA to other me-
tabolites (42). For example, the gene of an NAD+-dependent 
γ-glutamyl-γ-aminobutyraldehyde dehydrogenase (PuuC) 
of K. pneumoniae can be overexpressed. This enzyme is able 
to oxidize 3-HPA to 3-hydroxypropionic acid (3-HP). In that 
study puuC gene was cloned and overexpressed in K. pneu-
moniae DSM 2026 ∆dhaT (41). The recombinant puuC gene 
mutant can successfully produce 3.6 g/L of 3-HP in shake 
flask culture. In fed-batch fermentation, the recombinant K. 
pneumoniae ∆dhaT (puuC) strain produced 16.0 g/L of 3-HP 
and 16.8 g/L of 1,3-PD. The yield in 24 h reached 0.51 mol per 
mol of glycerol. 
As it is mentioned above, in order to gain better produc-
ers, the inactivation or overexpression of more than one gene 
can be carried out. Besides, knocking out the genes encod-
ing the production of byproducts and overexpressing useful 
genes simultaneously can give different advantages. Some 
other new biotechnology tools like genome shuffling, which 
can also be combined with inactivation or overexpression, 
could probably make the producers more efficient. Due to 
the modification of gene or even the genome, there are some 
limitations of these methods, for example, metabolic disor-
ders may occur. These joint methods and related problems 
deserve attention in the future (26).
CONVENTIONAL MUTAGENESIS METHODS
Induced mutation is one of the conventional and classical 
mutation methods in microorganism breeding field, which 
significantly improves the frequency of spontaneous muta-
tion by mutagens encompassing physical or chemical fac-
tors. Although induced mutation is a random mutagenesis, 
it is extensively used not only in highly productive industrial 
strains, but also in altering metabolic pathway of wild type 
strains to gain new metabolites or to express a particular phe-
notype (50). Therefore, these induced agents were carried out 
singly or jointly with the purpose of efficiency improvement 
in bioconversion from glycerol to 1,3-PD. The mechanisms of 
induced mutation are diverse and can be classified into point 
mutation (the effect of one base pair) and aberration (the ef-
fect of a length of chromosome). The performance of differ-
ent mutants is given in Table 2 (50-55).
Physical mutagenesis
Ultraviolet rays
Ultraviolet radiation is a simple and effective method of 
mutagenesis, and the effective UV wavelength for treatment 
is 200-300 nm. Among these wavelengths, 254 nm is the op-
timum one, because it is the maximum absorption of nucleic 
acid. Ultraviolet radiation can cause base transitions, trans-
versions, frameshift, mutation or deletion, resulting in the 
formation of mutants (56,57). Most researchers (50,54) had 
accomplished the UV mutagenesis of strains producing 1,3- 
-PD directly by ultraviolet lamp irradiation. The distance, time 
and power of UV irradiation can affect the mutagenesis ra-
tio. The UV parameters were investigated at different levels, 
and the appropriate level was determined by the mortality 
rate. The optimal mortality rate should be 90-95 % (58). After-
wards, the selected parameters were used to make mutants 
and the ideal mutants were screened. By this pattern, Lu et 
al. (50) chose K. pneumoniae as the focus of their research, 
in which UV mutagenesis of its protoplast was induced, in 
order to improve the tolerance of the strain to glycerol and 
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1,3-PD, and thus to obtain strains with high 1,3-PD produc-
tion. Two methods were designed to obtain the protoplast 
of K. pneumoniae. The samples were pretreated with glycine 
and then dissolved with lysozyme. After the mutagenesis of 
protoplasts, three high-yield strains (pK-1, K-4 and K-5) were 
obtained because of their tolerance to high concentration of 
glycerol and 1,3-PD. In fed-batch fermentation experiments, 
the 1,3-PD titres of pK-1, K-4 and K-5 were 70.24, 65.21 and 
75.51 g/L, respectively. Compared with the wild strain, whose 
production was 55.78 g/L, the 1,3-PD production of mutant 
strains was improved by 25.92, 16.91 and 35.37 %, respective-
ly. As a very common physical mutagen, ultraviolet radiation 
is always combined with other chemical mutagens to obtain 
better producers. 
Dielectric barrier discharge plasma 
Atmospheric pressure cold plasma is a non-equilibrium 
plasma at low temperature, which is the plasma at atmos-
pheric pressure when gas is ionized by the influence of ex-
ternal high energy, i.e. high voltage, strong magnetic field, 
radiation, etc. Gas can produce a large number of active sub-
stances in the ionization process, including charged parti-
cles, metastable substances with chemical activity, such as 
ozone, activated hydroxyl radicals, oxygen atoms, and ultra-
violet photon (59). These substances can interact with biolog-
ical molecules and organisms like enzymes and DNA. Plasma 
can cause oxidative damage of DNA, leading to the damage 
of DNA double chain structure and to the death or mutation 
of organisms (60). 
So far, the use of dielectric barrier discharge (DBD) plasma 
mutagenesis on 1,3-PD production has been reported (51). 
Dong et al. (61) used this method to evaluate K. pneumoniae 
strain with the capacity of producing 1,3-PD. Fig. 3 shows the 
diagram of DBD device they used, consisting of power supply 
and reactor. The reactor consists of a pair of circular alumin-
ium plate electrodes covered with quartz glass. The cell sus-
pension can be spread on the quartz glass and then treated 
with DBD plasma. 
DBD plasma was used as a single mutagenesis agent 
and a stable strain of K. pneumoniae (designated Kp-M2) 
was generated with improved 1,3-PD production. The strain 
was obtained by exposing the cells to DBD plasma before 
subjecting them to fermentation with glycerol as a carbon 
source. In batch fermentation, Kp-M2 strain grew faster and 
consumed glycerol more rapidly than the wild type. The fi-
nal yield of 1,3-PD was enhanced by 23 %. In fed-batch fer-
mentations, Kp-M2 also showed faster growth than wild 
type. Furthermore, in another work (51), a complex treat-
ment of plasma and LiCl was attempted, and a mutant strain 
designated KpM30 was obtained in a medium containing 
FeCl
3
 with selective pressure. The mutant showed a high ti-
tre of 1,3-PD (70.2 g/L, increased by 24.9 % compared with 
the wild strain), and its yield on glycerol was 0.576 mol/mol, 
increased by 17.7 % in fed-batch fermentation. Briefly, DBD 
plasma has antibacterial activity, the biological effect of im-
proving seed vigour, as well as the unique potential of mu-
tagenesis (62).
Table 2. Comparison of 1,3-propanediol production using various mutants by conventional mutagenesis methods
Method Mutagen Strain γ(titre)g/L
Y
g/g
Ratio of titre (mutant 
to wild type) Reference
Physical mutagenesis
UV rays K. pneumoniae ATCC 25955 75.51 0.51 1.35 (50)
DBD plasma K. pneumoniae KpM30 70.20 0.48 1.25 (51)
Chemical mutagenesis
UV and LiCl K. pneumoniae YMU1 69.54 0.42 1.63 (52)
NTG C. diolis DSM 15410 85 0.64 1.8 (53)
UV and LiCl K. pneumoniae LM03 66.74 - 1.33 (54)
DES C. butyricum ASL209 15.70 - 6.13 (55)
Y=yield, DBD=dielectric barrier discharge, NTG=N-methyl-N’-nitro-N-nitrosoguanidine, DES=diethyl sulfate
Fig. 3. Schematic diagram of the dielectric barrier discharge plasma 
device at atmospheric pressure (51)
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Other physical agents 
So far, there have been many other new physical mu-
tagenesis means applied to microbial breeding, and good 
results have been achieved (63). For example, mutants can 
be obtained by the X-ray, neutron, ion implantation, micro-
wave, ultrasonic or laser radiation, cosmic rays, etc. C. beijer-
inckii is used for butanol fermentation from a non-detoxified 
hemicellulosic hydrolysate of corn fibre treated with diluted 
sulfuric acid (SAHHC). This fermentation has similar bottle-
necks in 1,3-PD production, i.e. both the substrate inhibitor 
and the product inhibitor. Therefore, in order to overcome 
these disadvantages, low-energy ion implantation technol-
ogy was introduced to butanol fermentation. Guo et al. (64) 
used this technology to carry out the reconstruction of C. 
beijerinckii. As a result, they obtained mutant IB4, which had 
a high level of tolerance to the inhibitor. However, until now 
there have been few reports about the application of these 
new mutagenesis methods in the transformation of glycer-
ol to 1,3-PD. The above examples can provide references for 
improving the tolerance of 1,3-PD and improving its yield.
Chemical mutagenesis
Lithium chloride 
Lithium chloride (LiCl) is an alkali metal halide, which has 
no direct mutagenic effect by itself, but when combined with 
other mutagens, it often has good synergistic mutagenic ac-
tivity (65). LiCl is usually used in combination with UV mu-
tagenesis in breeding. Du et al. (52) obtained mutants by UV 
light and LiCl mutagenesis derived from the parent strain 
of K. pneumoniae. In this study, a novel redox potential (ox-
idoreduction potential [ORP])-based screening strategy was 
designed for the isolation of mutants with high 1,3-PD pro-
duction. LiCl was added to Luria-Bertani (LB) culture medium 
plates at a concentration of 2 g/L. Then the cell suspension 
in exponential growth phase was spread on these plates, 
which were put 40 cm below the UV light source (30 W) for 
30 s. Under the above conditions, approx. 5 out of 100 cells 
survived. 1,3-PD was measured by high-performance liquid 
chromatography after incubation at 37 °C in the dark for 48 
h. The highest 1,3-PD concentration of the mutant was 915 
mM, i.e. 69.54 g/L, which was 63.1 % higher than that of the 
wild strain. The distribution of metabolic flux analysis of this 
mutant indicated that the strengthened bioreductive branch 
contributed to the improved production of 1,3-PD. Wang et 
al. (54) also chose LiCl combined with other physicochemi-
cal agents to induce K. pneumoniae mutagenesis. Based on 
ion ray, ultraviolet light and LiCl mutation methods, product 
tolerance was increased, and as a result of that the conver-
sion ability of glycerol into 1,3-PD also increased. Compared 
with parent strain, the production of the two mutants LM03 
and LM05 was improved by 33 and 30 % respectively. A large 
number of studies suggests that the rate of positive muta-
tion by LiCl is much higher than the single UV mutagene-
sis, and protoplast mutagenesis by UV combined with LiCl is 
more liable than mycelium mutagenesis to obtain the high 
yield strains (52,58,65,66).
N-methyl-N’-nitro-N-nitrosoguanidine
N-methyl-N’-nitro-N-nitrosoguanidine (NTG) is an alkyl-
ating mutagenesis agent, which is a commonly used chemi-
cal mutagen. Many researchers focusing on NTG mutagene-
sis have found that NTG makes a strong preference for G/C to 
A/T transitions (63). In 1995, NTG was used for the mutagen-
esis of C. butyricum with the purpose of decreasing the sub-
strate and product inhibition (67). In fed-batch culture, 44 
% more glycerol was consumed and 50 % more 1,3-PD was 
produced by the mutant than by the wild type strain. Otte 
et al. (53) also used NTG as mutagen to enhance the yield 
of 1,3-PD by C. diolis DSM 15410 in a single-cell suspension. 
The cells were first treated with NTG solution for over 1 h at 
34 °C, then centrifuged and resuspended. Finally, they were 
spread onto agar plates containing different concentrations 
of 1,3-PD for tolerance screening, and higher yield producers, 
mutant 44 and 46, were obtained. Combined with genome 
shuffling (directed evolution of whole organisms via recur-
sive recombination at the genome level), an excellent pro-
ducer with a 1,3-PD yield of 85 g/L was obtained, which is 80 
% higher than that of the parental wildtype strain.
Diethyl sulfate 
Diethyl sulfate (DES) is another widely used alkylating 
mutagenesis agent. Using C. butyricum 209 as the original 
strain, Li et al. (55) obtained a mutant strain whose 1,3-PD 
yield was increased to 113 % by two rounds of DES mutagen-
esis. UV mutagenesis alone and UV combined with NTG mu-
tagenesis of this mutant were both carried out. 1,3-PD titre 
of the final mutant reached 15.7 g/L, 6.13 times higher than 
the original strain (the titre was 2.2 g/L). They used the single 
cell suspension method. Solid crystal can also be used in ran-
dom chemical mutagenesis. A crystal of mutagen was placed 
at the centre of each plate. Two plates without the mutagen 
were used as the control. After several minutes, liquid strain 
culture was spread on each plate, which were then incubat-
ed until bacterial growth was observed (68).
There are just a few simple physical agents used currently 
for the conventional mutagenesis. Technologies like atmos-
pheric and room temperature plasma have been used to pro-
duce new strains, and good results were obtained (52). There-
fore, complex agents or other violent factors are a promising 
choice. In summary, these conventional mutagenesis meth-
ods provide good choices to obtain high-productivity in-
dustrial strains or express a particular phenotype. Moreo-
ver, some disadvantages are also obvious. For example, these 
methods are random, and the mutation rate is much lower 
than when using genetic methods. High throughput screen-
ing should be used to isolate the positive strains, which en-
larges the working capacity. Therefore, proper attention 
should be paid to more efficient screening methods. 
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FERMENTATION PROCESSING
Genetic stability of engineered strains
The stability of the genetically engineered strains men-
tioned above was investigated to determine their behaviour 
in practical fermentation (45,69). After culturing for several 
generations, the titre or yield and the activity of key enzymes 
of 10-100 passages were still identical to that of passage 0, 
which indicated that the recombinants had good genetic 
stability. However, in the study of some strains like Kp-M1 
and Kp-M7 (69), their longevity profile was not very good 
(70,71). In order to increase their stability and make their re-
peated or continued use possible, many researchers adopted 
different methods to maintain the biological activity of engi-
neered strains. The first is to continuously conduct mutagen-
esis generation by generation (69). The second is to carry out 
stress treatment by adding the inhibitors like glycerol and 
1,3-PD into the fermentation broth (68). However, the most 
promising technique is immobilization of cells (31). The cells 
are fixed into a solid matrix or retained by a membrane. Apart 
from the fact that the stability of the enzyme is increased, 
cell immobilization also makes it possible to maintain the 
primitive state and high recovery rate of the enzyme, and 
the coenzyme factor can be added automatically. It has been 
demonstrated that cell immobilization techniques can sig-
nificantly increase 1,3-PD production and allow robust con-
tinuous production (31). Therefore, fermentation by using 
immobilized microorganisms is a great way to keep the lon-
gevity and stability of the biomass.
Different fermentation approaches
1,3-PD was mostly produced under anaerobic conditions, 
however, facultative anaerobic or microaerobic conditions 
were also reported (63). Therefore, appropriate bioreactors 
should be chosen according to their fermentation conditions. 
In addition, different fermentation approaches may get differ-
ent 1,3-PD yield or productivity, including batch, fed-batch, 
continuous feed and two-step continuous feed fermentation. 
The most common are batch and fed-batch fermentation. Pro-
duction parameters of 1,3-PD are given in Table 3 (36,70,72-75). 
FUTURE PROSPECTS
With the increasing prosperity of the global economy, 
the demand for energy sources is also increasing. In order 
to release the stress of the depletion of non-renewable re-
sources and an unsustainable environment, efforts are re-
cently being made worldwide to minimize the utilization of 
fossil fuels and to purify the biological routes with the pur-
pose of avoiding bulk chemicals. The biodiesel production 
and its conversion cater to this sustainable tendency. The 
boom of genetic engineering and analogous biotechnolo-
gy enables to debottleneck 1,3-PD production by microor-
ganisms. Future concerns and strategies about genetically 
engineered bacteria are mainly embodied in the following 
respects. The first is to acquire new gene resources with the 
metagenomics technology. For example, the genes that al-
low conversion of glycerol to 1,3-PD can be cloned into a 
bacterium producing glycerol from sugars, which may re-
solve the problem of substrate inhibition. The second is to 
improve the producers by metabolic engineering. Specific 
genes or metabolic pathways can be knocked in or out in 
order to achieve improved microbial features. These two 
approaches focus on the genetic engineering modification. 
Due to the randomness of changed genes by conventional 
mutagenesis methods, the isolation of producers with high 
titre or productivity is a time-consuming work. Therefore, 
the third concern is to design satisfying facilities to improve 
the work efficiency.
On the other hand, the downstream processing of 1,3-PD 
development is also an important concern. The lack of effi-
cient purification strategy is a hindrance to the commercial-
ization of 1,3-PD. The fermentation media contain multiple 
components, such as surplus glycerol, nutrient content, by-
products and salts. This challenge has to be resolved to make 
purified 1,3-PD economically available. The major methods 
for the purification and recovery that have been studied are 
reactive extraction, liquid-liquid extraction, evaporation, 
distillation, membrane filtration, pervaporation and ion ex-
change chromatography. After the separation, the other val-
ue-added byproducts can also be recovered, which also ca-
ters for the concept of sustainable development (76). 
Table 3. Different parameters for 1,3-propanediol production by various strains
Method Description Parameter value Strain Reference
Batch fermentation
Easy operation, short cycle, low 
contamination rate, low titre or 
yield, complicated kinetic parameter 
measurements
γ(titre)=78.5 g/L C. diolis GSHM 2 (72)
Υ=0.65 mol/mol C. butyricum YJH-09 (73)
r=0.78 g/(L·h) L. brevis N1E9.3.3 (74)
Fed-batch fermentation
Constant substrate concentration or 
feed rate, kinetic paremeter analysis, 
high productivity, possibility of 
contamination, species degeneration
γ(titre)=87.5 g/L K. pneumoniae 2-1 (36)
Υ=0.67 mol/mol K. pneumoniae DSM 4799 (75)
r=3.29 g/(L·h) K. pneumoniae KG1 (70)
Υ=yield, r=productivity
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Some researchers estimated the producing costs of 1,3- 
-PD fermentation and purification. In fermentation, one of the 
key factors influencing the unit price of 1,3-PD was the price 
of crude glycerol, whose market price in 2017 was about 300-
400 USD/t (77). Apart from that, in the purification process, 
the main expense focuses on the separation processes. Jiyan 
et al. (78) analyzed the cost of three consecutive separation 
processes after biological fermentation. The cost of each sep-
arate step is about 2200 USD/t. In addition, the labour cost or 
other extra costs also increase the price. Since the improve-
ment of final concentration and conversion rate can reduce 
the cost of production, the optimization and improvement of 
1,3-PD separation should still be strengthened so as to realize 
its further industrialization application in terms of the market 
price of 1,3-PD (4000 USD/t). 
CONCLUSIONS
Sustainable development and resource recycling includ-
ing bioconversion of 1,3-propanediol (1,3-PD) from glycer-
ol is a perpetual theme. The biological methods for 1,3-PD 
production using engineered strains is just a starting point. 
Various strategies have been dedicated to maximizing the 
production potential. Genetic engineering provides accu-
rate and directional ways to alter the producers and improve 
the yield, enabling the customization of metabolic pathway. 
Conventional mutagenesis enlarges the possibility of obtain-
ing desired performances which can be screened. Advan-
tages and disadvantages coexist in both genetic and con-
ventional methods and a lot more work needs to be done to 
overcome the obstacles in industrial biosynthesis of 1,3-PD. 
The joint implementation of the existing methods or the ex-
ploration of new biotechnologies is the only way forward 
to find genetically engineered strains that produce 1,3-PD.
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